Guangzheng Eye Hospital Group Co., Ltd.
Symbol: 002524.SZ
SHZ
4.16
CNYDzisiejsza cena rynkowa
211.9824
Wskaźnik P/E
0.0000
Wskaźnik PEG
2.12B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Guangzheng Eye Hospital Group Co., Ltd. (002524-SZ) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 307.1 | 91.1 | 65.4 | 89.3 | |||||||||||||||||
balance-sheet.row.short-term-investments | -143.74 | 0 | -68 | 31 | |||||||||||||||||
balance-sheet.row.net-receivables | 782.74 | 190.2 | 143.5 | 192.1 | |||||||||||||||||
balance-sheet.row.inventory | 151.98 | 29.6 | 57.3 | 53.2 | |||||||||||||||||
balance-sheet.row.other-current-assets | 23.34 | 5.6 | 3.3 | 5.9 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1265.15 | 316.5 | 269.5 | 340.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2511.93 | 619.7 | 687.6 | 744.2 | |||||||||||||||||
balance-sheet.row.goodwill | 1511.56 | 377.3 | 378.5 | 517.2 | |||||||||||||||||
balance-sheet.row.intangible-assets | 159.62 | 40 | 37 | 55.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1671.19 | 417.2 | 415.5 | 572.8 | |||||||||||||||||
balance-sheet.row.long-term-investments | 181.47 | 0 | 94 | 7.2 | |||||||||||||||||
balance-sheet.row.tax-assets | 182.98 | 49.7 | 40.6 | 40.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 376.81 | 146.3 | 50.2 | 123.6 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 4924.38 | 1232.9 | 1288 | 1488.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.account-payables | 1052.98 | 261.3 | 275.5 | 262.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 1503.14 | 383.2 | 360.8 | 289 | |||||||||||||||||
balance-sheet.row.tax-payables | 63.8 | 16 | 10.9 | 15.2 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 2004.97 | 493.8 | 448.9 | 505.7 | |||||||||||||||||
Deferred Revenue Non Current | 13.05 | 0 | 0 | 30 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.33 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 29.31 | 7.7 | 107.5 | 10.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2047.9 | 507.6 | 468.6 | 507.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1693.54 | 417.3 | 448.4 | 475.7 | |||||||||||||||||
balance-sheet.row.total-liab | 5054.77 | 1263.5 | 1282.7 | 1487.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 2068.45 | 518 | 515.4 | 516.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | -1219.92 | -299.7 | -308.4 | -214.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 200.82 | 0 | 46.5 | 16.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.22 | 65 | 19.6 | 21.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1123.57 | 283.3 | 273.1 | 340.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 11.18 | 2.6 | 1.7 | 0.8 | |||||||||||||||||
balance-sheet.row.total-equity | 1134.75 | 285.9 | 274.8 | 341.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6189.53 | - | - | - | |||||||||||||||||
Total Investments | 75.6 | 19.1 | 26 | 38.2 | |||||||||||||||||
balance-sheet.row.total-debt | 3508.11 | 877 | 809.7 | 794.7 | |||||||||||||||||
balance-sheet.row.net-debt | 3201.01 | 785.9 | 744.3 | 736.4 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 18.29 | -77.8 | 36.4 | 32.1 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | -23.36 | 100 | 106.4 | 62.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | -3.08 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0.15 | 2.5 | 6 | 13.1 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -108.9 | 27.9 | 32.8 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 48.7 | -23.6 | 28.8 | ||||||||||||||||
cash-flows.row.inventory | 0 | -8.7 | 16.9 | -3.9 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -146.7 | 35.8 | 18.8 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 39.32 | 210.7 | -30.1 | 25.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 31.18 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.acquisitions-net | 25.73 | 1.8 | 83.9 | 194.5 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -25.73 | -116.4 | -262.1 | -543 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4.07 | 54.7 | 228.4 | 33.9 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.92 | 0 | 3.5 | 7.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -6.23 | -100.6 | 1.2 | -369.6 | ||||||||||||||||
cash-flows.row.debt-repayment | -170.2 | -232 | -467 | -130.7 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.1 | 22.7 | 29.5 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3.1 | -22.7 | -29.5 | ||||||||||||||||
cash-flows.row.dividends-paid | -15.3 | -11.9 | -16.5 | -46.6 | ||||||||||||||||
cash-flows.row.other-financing-activites | 68.2 | 232.2 | 273.7 | 255.3 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -53.06 | -11.8 | -209.8 | 78 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -3.24 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -29.13 | 12 | -63.2 | -136.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 255.13 | 57 | 45 | 108.3 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 284.26 | 45 | 108.3 | 244.8 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 31.18 | 124.3 | 145.4 | 155 | ||||||||||||||||
cash-flows.row.capital-expenditure | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.free-cash-flow | 9.46 | 83.6 | 92.9 | 92.9 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1058.07 | 1074.9 | 767.4 | 1044.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 689.43 | 697.9 | 575.9 | 709.2 | |||||||||||||||||
income-statement-row.row.gross-profit | 368.64 | 377 | 191.5 | 335.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 5.26 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 37.86 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 337.23 | 328.7 | 281.5 | 334.3 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1026.66 | 1026.6 | 857.4 | 1043.5 | |||||||||||||||||
income-statement-row.row.interest-income | 0.76 | 0.7 | 0.8 | 0.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 40.76 | 100.3 | 100 | 106.4 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 35.43 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -5.32 | 7 | 98.6 | 77 | |||||||||||||||||
income-statement-row.row.income-before-tax | -5.28 | 7.9 | -75.6 | 44.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -3.23 | -1.8 | 2.2 | 8.5 | |||||||||||||||||
income-statement-row.row.net-income | -1.62 | 9.3 | -77.8 | 36.9 |
Często zadawane pytania
Ile wynosi Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) aktywów ogółem?
Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) całkowite aktywa to 1549365088.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 447607126.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.351.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.001.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.009.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.007.
Co to jest Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 9255045.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 877008780.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 328663038.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 65054312.000.